Respiratory disease
Respiratory diseases encompass a wide range of pathological conditions affecting the lungs and respiratory tract, including acute infections like the common cold and influenza, chronic conditions such as asthma and chronic bronchitis, and life-threatening diseases like pneumonia, tuberculosis, and lung cancer. These conditions can be caused by factors like smoking, air pollution, and infectious agents, and involve various parts of the respiratory system including the trachea, bronchi, alveoli, and pleura.
Health Outcomes
- Decreased Oxygenated Hemoglobin Level
- Elevated Antipneumococcal IgA Levels in Bronchoalveolar Lavage Fluid
- Enhanced Influenza Resistance
- Enhanced Resistance to Infections
- Enhanced Resistance to Streptococcus Pneumoniae Infection
- Improved Antibiotic Sensitivity
- Improved Asthmatic Condition
- Improved Deep Lung Delivery Feasibility
- Improved Immune Mechanisms Against S. pneumoniae
- Improved JMCIS Score
- Improved Leukocyte Recruitment
- Improved Lung Barrier Function
- Improved Lung Function
- Improved Mucosal Immunity
- Improved Resistance to Infections
- Improved Resistance to Respiratory Candida Albicans Infection
- Increased Adverse Event Incidence
- Increased Anti-Viral Factor Expression in Lung
- Increased Antibody Levels for Avian Influenza Virus
- Increased Bacillus Spore Counts
- Increased Dispersal of Pathogenic Bacteria
- Increased IL-8 Levels at 24 Hours
- Increased Incidence of Pulmonary Exacerbations
- Induction of Antimicrobial Chemokines
- Inhibition of RSV Replication
- Managed Cystic Fibrosis
- Modulated Pulmonary Innate Immune Microenvironment
- Modulated Pulmonary Innate Immune Response
- Modulation of Pulmonary Innate Immune Function
- Not Assessable From Provided Abstract
- Persistent Nasal Colonization
- Preserved Anti-pseudomonal Activity
- Reduced Airway Pathological Responses
- Reduced Airway Remodeling
- Reduced Bacterial Load in Lungs
- Reduced Common Cold Incidence in Susceptible Populations
- Reduced Exposure to Harmful Substances
- Reduced Frequency of Upper Respiratory Tract Infections
- Reduced Hypoxia
- Reduced ICU Length of Stay
- Reduced Incidence of Bacterial Pneumonia
- Reduced Infant Wheeze
- Reduced Lifetime Prevalence of Wheeze
- Reduced Lung Histopathology Scores
- Reduced Lung Injury
- Reduced Lung Viral Proliferation
- Reduced Mechanical Ventilation Duration
- Reduced Mold Presence
- Reduced PICU Discharge Time
- Reduced Peak Inspiratory Pressure
- Reduced Pediatric Exacerbations
- Reduced Pediatric Intensive Care Unit Stay
- Reduced Pneumococcal Adherence
- Reduced Pseudomonas aeruginosa-Induced Damage
- Reduced Pulmonary Exacerbations
- Reduced Pulmonary Free-CML
- Reduced RSV Replication
- Reduced Rhinovirus Nasal Lavage Titer
- Reduced Severity of Acute Respiratory Infection